"We Have Gone Through Hardships But Our Passion Remains High," Says Glenn Saldanha, Managing Director, Glenmark Pharma: An Interview With PharmAsia News (Part 1 of 2)

Glenn Saldanha, Managing Director, Glenmark Pharmaceuticals has been speaking about discovery research in India for more than a decade but his critics from bigger companies played down those efforts as high decibel talk, over-ambitious thoughts and a few even called them day dreaming moves. But five out-licensing deals in seven years with companies like Eli Lilly, Merck Serono and Sanofi-Aventis have transformed the way Glenmark Pharma is seen by the world today. Saldanha recalls the early days of his programs, the learning from his research partners and what his pipeline of drugs hold for the future in an exclusive interview with PharmAsia News' India bureau.